FR2628972B1 - Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer - Google Patents

Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer

Info

Publication number
FR2628972B1
FR2628972B1 FR8903812A FR8903812A FR2628972B1 FR 2628972 B1 FR2628972 B1 FR 2628972B1 FR 8903812 A FR8903812 A FR 8903812A FR 8903812 A FR8903812 A FR 8903812A FR 2628972 B1 FR2628972 B1 FR 2628972B1
Authority
FR
France
Prior art keywords
cardiac
preparing
pharmaceutical compositions
cardiovascular system
compositions acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8903812A
Other languages
English (en)
French (fr)
Other versions
FR2628972A1 (fr
Inventor
Nagy Peter Literati
Radvany-Nee-Hegedues Erzsebet
Boros Maria
Szilbereky Jeno
Blasko Gyoergy
Gachalyi Bela
Hamar-Nee-Nemes Gizella
Nemeth Gabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREX KFT
Original Assignee
BIOREX KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREX KFT filed Critical BIOREX KFT
Publication of FR2628972A1 publication Critical patent/FR2628972A1/fr
Application granted granted Critical
Publication of FR2628972B1 publication Critical patent/FR2628972B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
FR8903812A 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer Expired - Fee Related FR2628972B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (2)

Publication Number Publication Date
FR2628972A1 FR2628972A1 (fr) 1989-09-29
FR2628972B1 true FR2628972B1 (fr) 1994-09-23

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8903812A Expired - Fee Related FR2628972B1 (fr) 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer

Country Status (15)

Country Link
JP (1) JPH0222228A (enrdf_load_stackoverflow)
KR (1) KR890014104A (enrdf_load_stackoverflow)
BE (1) BE1003021A3 (enrdf_load_stackoverflow)
CA (1) CA1319607C (enrdf_load_stackoverflow)
CH (1) CH677732A5 (enrdf_load_stackoverflow)
DE (1) DE3909707A1 (enrdf_load_stackoverflow)
ES (1) ES2014060A6 (enrdf_load_stackoverflow)
FI (1) FI891438L (enrdf_load_stackoverflow)
FR (1) FR2628972B1 (enrdf_load_stackoverflow)
GB (1) GB2216421A (enrdf_load_stackoverflow)
HU (1) HU210122B (enrdf_load_stackoverflow)
IT (1) IT1229205B (enrdf_load_stackoverflow)
LU (1) LU87488A1 (enrdf_load_stackoverflow)
NL (1) NL8900742A (enrdf_load_stackoverflow)
SE (1) SE8901041L (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
NZ548508A (en) * 2002-05-03 2008-04-30 Pronova Biocare As Use of EPA and DHA in preventing cerebral damage wherein the dosage ranges from 0.5 to 5.0g of EPA and/or DHA daily
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
KR101268206B1 (ko) * 2004-08-09 2013-05-27 엔지모테크 리미티드 당뇨병용 식품
EP1796726A2 (en) 2004-08-10 2007-06-20 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
HU202088B (en) * 1987-03-18 1991-02-28 Caola Kozmetikai Method for producing dietetic preparation
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition

Also Published As

Publication number Publication date
JPH0222228A (ja) 1990-01-25
LU87488A1 (fr) 1990-10-02
IT8919876A0 (it) 1989-03-23
IT1229205B (it) 1991-07-25
FI891438A0 (fi) 1989-03-23
KR890014104A (ko) 1989-10-21
SE8901041D0 (sv) 1989-03-23
FR2628972A1 (fr) 1989-09-29
GB2216421A (en) 1989-10-11
FI891438A7 (fi) 1989-09-24
CA1319607C (en) 1993-06-29
CH677732A5 (enrdf_load_stackoverflow) 1991-06-28
SE8901041L (sv) 1989-09-24
NL8900742A (nl) 1989-10-16
FI891438L (fi) 1989-09-24
GB8906856D0 (en) 1989-05-10
HUT60436A (en) 1992-09-28
DE3909707A1 (de) 1989-10-05
ES2014060A6 (es) 1990-06-16
BE1003021A3 (fr) 1991-10-29
HU210122B (en) 1995-02-28

Similar Documents

Publication Publication Date Title
FR2628972B1 (fr) Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
FR2628324B1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
IT8222684A0 (it) Sospensione di carbone-acqua eprocedimento per la sua preparazione.
NL193652B (nl) Zoete lekkernij en werkwijze voor de bereiding daarvan.
FR2618788B1 (fr) Copolymere sequence et procede pour le preparer
FI881303A7 (fi) Menetelmä ibuprofeenin valmistamiseksi
EP0520987A4 (en) METHOD FOR CONTROLLING APPETITE BY ADMINISTRATION OF TETRAHYDRO-G (B) CARBOLINE DERIVATIVES.
FR2692442B1 (fr) Preparation huileuse et procede pour la preparer.
FR2612399B1 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation
FI872831A7 (fi) Menetelmä farmaseuttisten seosten valmistamiseksi.
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
FR2663813B1 (fr) Procede et moyens pour la formation de tunnels de culture.
FR2576900B1 (fr) Derives de cyclohepto-imidazole 2-substitue, agents anti-ulcereux et procede pour leur preparation
IT8719700A0 (it) 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
FR2653998B1 (fr) Solution injectable et procede pour la preparer.
FR2604356B1 (fr) Compositions pharmaceutiques transdermiques multicouches ayant un effet prolonge et procede pour les preparer
FI885839A7 (fi) Menetelmä tioformamaidijohdannaisten valmistamiseksi
IT1243739B (it) L-carnitina deidrogenasi e procedimento per la sua produzione.
FR2586180B3 (fr) Procede pour realiser un meuble de repos articule et meuble obtenu par le procede
FI883265A7 (fi) Menetelmä -fluoriketonien valmistamiseksi.
NL193192B (nl) Oxicamderivaat, farmaceutisch preparaat dat het derivaat bevat en werkwijze voor het bereiden van oxicamderivaten.
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.
ITRM920813A0 (it) Biostruttura epitelio-supporto tubulare e metodo per la sua preparazione.

Legal Events

Date Code Title Description
ST Notification of lapse